May 15, 2019
Oncopeptides Announces Melflufen Data Accepted for Presentation at 2019 ASCO Annual Meeting
Media
May 15, 2019
GenSight Biologics reports positive 96-week data from REVERSE Phase III clinical trial of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON)
May 14, 2019
Altimmune Announces First Quarter 2019 Financial Results and Provides a Business Update
May 10, 2019
MIPS – World’s First Safety Helmet With MIPS Brain Protection System Released
May 10, 2019
Q1 2019 General Market Overview
May 09, 2019
Pulmonx Closes $65 Million Financing and Adds Chief Financial Officer
May 09, 2019
Targovax ASA: First quarter 2019 results
May 09, 2019
Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Academy of Neurology Annual Meeting
May 08, 2019
Altimmune to Announce First Quarter 2019 Financial Results on May 15
May 08, 2019
NEW CEO OF MIPS